Citations

Clear

1575 citation(s) found for "Im, Gene".

Plasma Copy Number Alteration-Based Prognostic and Predictive Multi-Gene Risk Score in Metastatic Castration-Resistant Prostate Cancer
Huang, Jinyong , Du, Meijun , Soupir, Alex C. , Wang, Liewei , Tan, Winston , Kilari, Deepak , Park, Jong Y. , Huang, Chiang‐Ching , Kohli, Manish , Wang, Liang , Soupir, Alex , Park, Jong Y , Huang, Chiang-Ching , Kohli, Manish , Wang, Liang , Kalari, Krishna R.

Mayo Clinic

Cancers | September 28, 2022 | Volume: 14 | Issue: 19 | Pages: 4714

10.3390/cancers14194714 | PMID 36230636 Get It

Prostate cancer (PCa) accounted for more than 34,000 deaths in US males [...]
Activity of a hypochlorous acid‐producing electrochemical bandage as assessed with a porcine explant biofilm model
Tibbits, Gretchen , Mohamed, Abdelrhman , Gelston, Suzanne , Flurin, Laure , Raval, Yash S. , Greenwood‐Quaintance, Kerryl E. , Patel, Robin , Beyenal, Haluk , Patel, Robin , Mohamed, A , Beyenal, H , Greenwood-Quaintance, Kerryl , Raval, Yash S.

Mayo Clinic

Biotechnology and Bioengineering | September 28, 2022 | Volume: 120 | Issue: 1 | Pages: 250-259

10.1002/bit.28248 | PMID 36168277 Get It

AbstractThe activity of a hypochlorous acid‐producing electrochemical bandage (e‐bandage) in preventing methicillin‐resistant Staphylococcus aureus infection (MRSA) infection and removing biofilms formed by MRSA was assessed using a porcine explant biofilm model. e‐Bandages inhibited S. aureus infection (p = 0.029) after 12 h (h) of exposure and reduced 3‐day biofilm viable cell counts after 6, 12, and 24 h exposures (p = 0.029). Needle‐type microelectrodes were used to assess HOCl concentrations in explant tissue as a result of e‐bandage treatment; toxicity associated with e‐bandage treatment was evaluated. HOCl concentrations in infected and uninfected explant tissue varied between 30 and 80 µM, decreasing with increasing distance from the e‐bandage. Eukaryotic cell viability was reduced by an average of 71% and 65% in fresh and day 3‐old explants, respectively, when compared to explants exposed to nonpolarized e‐bandages. HOCl e‐bandages are a promising technology that can be further developed as an antibiotic‐free treatment for wound biofilm infections.
CYCLIN K down-regulation induces androgen receptor gene intronic polyadenylation, variant expression and PARP inhibitor vulnerability in castration-resistant prostate cancer
Wei, Ting , Ding, Donglin , Zhang, Jianong , He, Housheng Hansen , Wang, Liguo , Sun, Rui , Wei, Ting , He, Housheng Hansen , Wang, Liguo , Sun, Rui , Chen, Sujun , Huang, Haojie , Sun, Rui

Mayo Clinic

Proceedings of the National Academy of Sciences | September 21, 2022 | Volume: 119 | Issue: 39 | Pages: No page available

10.1073/pnas.2205509119 | PMID 36129942 Get It

Androgen receptor (AR) messenger RNA (mRNA) alternative splicing variants (AR-Vs) are implicated in castration-resistant progression of prostate cancer (PCa), although the molecular mechanism underlying the genesis of AR-Vs remains poorly understood. The CDK12 gene is often deleted or mutated in PCa and CDK12 deficiency is known to cause homologous recombination repair gene alteration or BRCAness via alternative polyadenylation (APA). Here, we demonstrate that pharmacological inhibition or genetic inactivation of CDK12 induces AR gene intronic (intron 3) polyadenylation (IPA) usage, AR-V expression, and PCa cell resistance to the antiandrogen enzalutamide (ENZ). We further show that AR binds to the CCNK gene promoter and up-regulates CYCLIN K expression. In contrast, ENZ decreases AR occupancy at the CCNK gene promoter and suppresses CYCLIN K expression. Similar to the effect of the CDK12 inhibitor, CYCLIN K degrader or ENZ treatment promotes AR gene IPA usage, AR-V expression, and ENZ-resistant growth of PCa cells. Importantly, we show that targeting BRCAness induced by CYCLIN K down-regulation with the PARP inhibitor overcomes ENZ resistance. Our findings identify CYCLIN K down-regulation as a key driver of IPA usage, hormonal therapy–induced AR-V expression, and castration resistance in PCa. These results suggest that hormonal therapy–induced AR-V expression and therapy resistance are vulnerable to PARP inhibitor treatment.
Allogeneic haematopoietic cell transplant in patients with relapsed/refractory anaplastic large cell lymphoma
Furqan, Fateeha , Ahn, Kwang Woo , Abutalib, Syed A., Ahmed, Sairah , Kharfan‐Dabaja, Mohamed A. , Friedberg, Johnathan, Gregory, Tara, Hill, LaQuisa C. , Sterling, Cole , Barta, Stephan K., Herrera, Alex F. , Sauter, Craig S. , Ahmed, Sairah , Perales, Miguel-Angel , Hamadani, Mehdi , Hill, LaQuisa C , Chen, Yue , Kaur, Manmeet, Ahmed, Nausheen , Shadman, Mazyar , Perales, Miguel‐Angel , Zain, Jasmine , Hamadani, Mehdi

Mayo Clinic

British Journal of Haematology | September 19, 2022 | Volume: 200 | Issue: 1 | Pages: 54-63

10.1111/bjh.18467 | PMID 36120837 Get It

Summary The prognosis of relapsed/refractory (R/R) anaplastic large cell lymphoma (ALCL) is poor. Large studies evaluating outcomes of allogeneic haematopoietic cell transplantation (allo‐HCT) in systemic R/R ALCL are not available. Using the Center for International Blood and Marrow Transplant Research (CIBMTR) database, we evaluated outcomes of 182 adults (aged ≥18 years) with R/R ALCL undergoing allo‐HCT between 2008 and 2019. Non‐relapse mortality (NRM), disease relapse/progression (REL), progression‐free survival (PFS), and overall survival (OS) were modelled using Cox proportional hazards models. The median (range) follow‐up of survivors was 62 (3–148) months. The 1‐year NRM was 18%. The 5‐year REL, PFS and OS were 32%, 41% and 56% respectively. On multivariable regression analysis African American race (hazard ratio [HR] 2.7, 95% confidence interval [CI] 1.6–4.8; p < 0.001) and refractory disease at allo‐HCT (HR 3.2, 95% CI 1.6–6.2; p < 0.001) were predictive of inferior OS. Similarly, African‐American race (HR 2.1, 95% CI 1.3–3.4; p = 0.003), other minority race (HR 2.5, 95% CI 1.2–5.3; p = 0.02) and refractory disease (HR 2.2, 95% CI 1.2–4.3; p = 0.01) were predictive of inferior PFS. These data, demonstrate that allo‐HCT can result in durable disease control in a sizable proportion of patients with R/R ALCL. Refractory disease and racial minority status predicted inferior allo‐HCT outcomes. Whether the inferior outcomes of racial minorities with R/R ALCL after allo‐HCT are driven by differences in disease biology or disparities in post allo‐HCT care, or both, requires further investigation.
Efficacy and toxicity of hydrogen peroxide producing electrochemical bandages in a porcine explant biofilm model
Tibbits, Gretchen , Mohamed, Abdelrhman , Gelston, Suzanne , Flurin, Laure , Raval, Yash S. , Greenwood‐Quaintance, Kerryl E. , Patel, Robin , Beyenal, Haluk , Greenwood-Quaintance, Kerryl , Patel, Robin , Mohamed, A , Beyenal, H , Raval, Yash S.

Mayo Clinic

Journal of Applied Microbiology | September 8, 2022 | Volume: 133 | Issue: 6 | Pages: 3755-3767

10.1111/jam.15812 | PMID 36073322 Get It

Abstract Aims Effects of H2O2 producing electrochemical-bandages (e-bandages) on methicillin-resistant Staphylococcus aureus colonization and biofilm removal were assessed using a porcine explant biofilm model. Transport of H2O2 produced from the e-bandage into explant tissue and associated potential toxicity were evaluated. Methods and Results Viable prokaryotic cells from infected explants were quantified after 48 h treatment with e-bandages in three ex vivo S. aureus infection models: (1) reducing colonization, (2) removing young biofilms and (3) removing mature biofilms. H2O2 concentration-depth profiles in explants/biofilms were measured using microelectrodes. Reductions in eukaryotic cell viability of polarized and nonpolarized noninfected explants were compared. e-Bandages effectively reduced S. aureus colonization (p = 0.029) and reduced the viable prokaryotic cell concentrations of young biofilms (p = 0.029) with limited effects on mature biofilms (p &gt; 0.1). H2O2 penetrated biofilms and explants and reduced eukaryotic cell viability by 32–44% compared to nonpolarized explants. Conclusions H2O2 producing e-bandages were most active when used to reduce colonization and remove young biofilms rather than to remove mature biofilms. Significance and Impact of Study The described e-bandages reduced S. aureus colonization and young S. aureus biofilms in a porcine explant wound model, supporting their further development as an antibiotic-free alternative for managing biofilm infections.
Vasculogenic gene therapy: No role for revitalization of structural bone allografts
Rezaie, Elisa S., Visser, Noortje J., Berg, Catherine van den, Bishop, Allen T. , van den Berg, Catherine, Bishop, Allen T , Shin, Alexander Y.

Mayo Clinic

Journal of Orthopaedic Research | September 5, 2022 | Volume: 41 | Issue: 5 | Pages: 1014-1021

10.1002/jor.25438 | PMID 36058614 Get It

AbstractSegmental bone defects are often performed with cryopreserved allografts. They provide immediate stability, but risk nonunion, infection and late stress fracture. Improving the rate and extent of bone revitalization may improve results. Angiogenesis from surgically placed arteriovenous (AV) bundles improves bone blood flow and vitality in cryopreserved rat femora, augmented by vasculogenic growth factors. This study tests the same principal in Yucatan mini‐pigs with a tibial diaphyseal defect, combining surgical angiogenesis with angiogenic gene therapy within cryopreserved orthotopically‐placed allografts. Tibial diaphyseal defects were reconstructed with cryopreserved allografts and rigid internal fixation in 16 mini pigs. Half of the cranial tibial AV bundles placed within the allograft medullary canal were transfected with an adeno‐associated virus containing vascular endothelial growth factor (VEGF) and platelet‐derived growth factor (PDGF) genes (AAV9.VEGF.PDGF). Bone remodeling, angiogenesis, and allograft healing were assessed. During the postoperative survival period 5 of 8 transfected animals developed cutaneous benign vascular lesions at sites remote from the operated hindlimb, causing excessive bleeding. Within the allograft, both medullary (p = 0.013) and cortical (p = 0.009) vascular volumes were higher and vessels more mature than nontransfected allografts. Bone turnover (p = 0.013), bone mineralization (p = 0.018), bone healing (p = 0.008) and graft incorporation (p = 0.006) were all significantly higher in the gene therapy group. In a large animal tibial defect model, gene therapy of implanted AV bundles improved revascularization, remodeling and healing of cryopreserved allografts used for limb reconstruction. However, benign vascular lesions causing excessive bleeding developed in 5 out of 8 pigs transfected with AAV containing genes for VEGF and PDGF. This unforeseen complication makes vasculogenic gene therapy unacceptable for clinical use.
A missense mutation in the proprotein convertase gene furinb causes hepatic cystogenesis during liver development in zebrafish
Ellis, Jillian L., Evason, Kimberley , Fourman, Makenzie N. , Liu, Jiandong , Delous, Marion , Fiddes, Ian T. , Otis, Jessica P. , Houvras, Yariv , Stainier, Didier Y. R. , Yin, Chunyue , Yin, Chunyue , Zhang, Changwen, Ninov, Nikolay , Vanhollebeke, Benoît , Farber, Steven , Xu, Xiaolei , Lin, Xueying

Mayo Clinic

Hepatology Communications | August 26, 2022 | Volume: 6 | Issue: 11 | Pages: 3083-3097

10.1002/hep4.2038 | PMID 36017776 Get It

Abstract Hepatic cysts are fluid‐filled lesions in the liver that are estimated to occur in 5% of the population. They may cause hepatomegaly and abdominal pain. Progression to secondary fibrosis, cirrhosis, or cholangiocarcinoma can lead to morbidity and mortality. Previous studies of patients and rodent models have associated hepatic cyst formation with increased proliferation and fluid secretion in cholangiocytes, which are partially due to impaired primary cilia. Congenital hepatic cysts are thought to originate from faulty bile duct development, but the underlying mechanisms are not fully understood. In a forward genetic screen, we identified a zebrafish mutant that developed hepatic cysts during larval stages. The cyst formation was not due to changes in biliary cell proliferation, bile secretion, or impairment of primary cilia. Instead, time‐lapse live imaging data showed that the mutant biliary cells failed to form interconnecting bile ducts because of defects in motility and protrusive activity. Accordingly, immunostaining revealed a disorganized actin and microtubule cytoskeleton in the mutant biliary cells. By whole‐genome sequencing, we determined that the cystic phenotype in the mutant was caused by a missense mutation in the furinb gene, which encodes a proprotein convertase. The mutation altered Furinb localization and caused endoplasmic reticulum (ER) stress. The cystic phenotype could be suppressed by treatment with the ER stress inhibitor 4‐phenylbutyric acid and exacerbated by treatment with the ER stress inducer tunicamycin. The mutant liver also exhibited increased mammalian target of rapamycin (mTOR) signaling. Treatment with mTOR inhibitors halted cyst formation at least partially through reducing ER stress. Conclusion : Our study has established a vertebrate model for studying hepatic cystogenesis and illustrated the contribution of ER stress in the disease pathogenesis.
Comparison of replicating and nonreplicating vaccines against SARS-CoV-2
Mudrick, Haley , Massey, Shane , McGlinch, Erin B. , Parrett, Brian J. , Hemsath, Jack R. , Barry, Mary E., Rubin, Jeffrey D. , Uzendu, Chisom, Hansen, Michael J. , Erskine, Courtney L. , Keulen, Virginia P. Van , Drelich, Aleksandra , Panos, Joseph A. , Peikert, Tobias, Block, Matthew S. , Tseng, Chien‐Te K. , Olivier, Gloria , Barry, Michael A. , Mudrick, Haley E , Van Keulen, Virginia P , Fida, Madiha , Suh, Gina A , Block, Matthew S , Tseng, Chien-Te Kent , Olivier, Gloria , Barry, Michael A , Fida, Madiha , Suh, Gina A.

Mayo Clinic

Science Advances | August 24, 2022 | Volume: 8 | Issue: 34 | Pages: No page available

10.1126/sciadv.abm8563 | PMID 36001674 Get It

Most gene-based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are nonreplicating vectors. They deliver the gene or messenger RNA to the cell to express the spike protein but do not replicate to amplify antigen production. This study tested the utility of replication in a vaccine by comparing replication-defective adenovirus (RD-Ad) and replicating single-cycle adenovirus (SC-Ad) vaccines that express the SARS-CoV-2 spike protein. SC-Ad produced 100 times more spike protein than RD-Ad and generated significantly higher antibodies against the spike protein than RD-Ad after single immunization of Ad-permissive hamsters. SC-Ad–generated antibodies climbed over 14 weeks after single immunization and persisted for more than 10 months. When the hamsters were challenged 10.5 months after single immunization, a single intranasal or intramuscular immunization with SC-Ad-Spike reduced SARS-CoV-2 viral loads and damage in the lungs and preserved body weight better than vaccination with RD-Ad-Spike. This demonstrates the utility of harnessing replication in vaccines to amplify protection against infectious diseases.
Intratumoral Resolution of Driver Gene Mutation Heterogeneity in Renal Cancer Using Deep Learning
Acosta, Paul H. , Panwar, Vandana, Jarmale, Vipul , Christie, Alana , Jasti, Jay, Margulis, Vitaly , Rakheja, Dinesh , Cheville, John C. , Leibovich, Bradley C. , Parker, Alexander S. , Brugarolas, James , Kapur, Payal , Rajaram, Satwik , Rakheja, Dinesh , Brugarolas, James , Kapur, Payal

Mayo Clinic

Cancer Research | August 3, 2022 | Volume: 82 | Issue: 15 | Pages: 2792-2806

10.1158/0008-5472.can-21-2318 | PMID 35654752 Get It

Abstract Intratumoral heterogeneity arising from tumor evolution poses significant challenges biologically and clinically. Dissecting this complexity may benefit from deep learning (DL) algorithms, which can infer molecular features from ubiquitous hematoxylin and eosin (H&E)–stained tissue sections. Although DL algorithms have been developed to predict some driver mutations from H&E images, the ability of these DL algorithms to resolve intratumoral mutation heterogeneity at subclonal spatial resolution is unexplored. Here, we apply DL to a paradigm of intratumoral heterogeneity, clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer. Matched IHC and H&E images were leveraged to develop DL models for predicting intratumoral genetic heterogeneity of the three most frequently mutated ccRCC genes, BAP1, PBRM1, and SETD2. DL models were generated on a large cohort (N = 1,282) and tested on several independent cohorts, including a TCGA cohort (N = 363 patients) and two tissue microarray (TMA) cohorts (N = 118 and 365 patients). These models were also expanded to a patient-derived xenograft (PDX) TMA, affording analysis of homotopic and heterotopic interactions of tumor and stroma. The status of all three genes could be inferred by DL, with BAP1 showing the highest sensitivity and performance within and across tissue samples (AUC = 0.87–0.89 on holdout). BAP1 results were validated on independent human (AUC = 0.77–0.84) and PDX (AUC = 0.80) cohorts. Finally, BAP1 predictions correlated with clinical outputs such as disease-specific survival. Overall, these data show that DL models can resolve intratumoral heterogeneity in cancer with potential diagnostic, prognostic, and biological implications. Significance: This work demonstrates the potential for deep learning analysis of histopathologic images to serve as a fast, low-cost method to assess genetic intratumoral heterogeneity. See related commentary by Song et al., p. 2672
A Diagnostic Gene Expression Signature for Bladder Cancer Can Stratify Cases into Prescribed Molecular Subtypes and Predict Outcome
Chen, Runpu , Pagano, Ian , Murakami, Kaoru , Goodison, Steve , Vairavan, Ramanathan, Tahsin, Malak , Rosser, Charles J. , Furuya, Hideki , Tahsin, Malak , Rosser, Charles J , Furuya, Hideki , Sun, Yijun , Black, Peter C.

Mayo Clinic

Diagnostics | July 25, 2022 | Volume: 12 | Issue: 8 | Pages: 1801

10.3390/diagnostics12081801 | PMID 35892512 Get It

Bladder cancer is a biologically heterogeneous disease with variable clinical presentations, outcomes and responses to therapy. Thus, the clinical utility of single biomarkers for the detection and prediction of biological behavior of bladder cancer is limited. We have previously identified and validated a bladder cancer diagnostic signature composed of 10 biomarkers, which has been incorporated into a multiplex immunoassay bladder cancer test, Oncuria™. In this study, we evaluate whether these 10 biomarkers can assist in the prediction of bladder cancer clinical outcomes. Tumor gene expression and patient survival data from bladder cancer cases from The Cancer Genome Atlas (TCGA) were analyzed. Alignment between the mRNA expression of 10 biomarkers and the TCGA 2017 subtype classification was assessed. Kaplan–Meier analysis of multiple gene expression datasets indicated that high expression of the combined 10 biomarkers correlated with a significant reduction in overall survival. The analysis of three independent, publicly available gene expression datasets confirmed that multiplex prognostic models outperformed single biomarkers. In total, 8 of the 10 biomarkers from the Oncuria™ test were significantly associated with either luminal or basal molecular subtypes, and thus, the test has the potential to assist in the prediction of clinical outcome.